Research Article

The effectiveness of oral protein supplementation in malnourished peritoneal dialysis patients

Volume: 7 Number: 2 March 4, 2021
EN

The effectiveness of oral protein supplementation in malnourished peritoneal dialysis patients

Abstract

Objectives: Malnutrition is a common problem in chronic renal disease patients during pre-dialysis and dialysis, leading to increased cardiovascular diseases and mortality. This study aimed to evaluate the efficacy of supplemental protein supplementation on malnutrition in peritoneal dialysis patients.

Methods: Eighty-four stable adult peritoneal dialysis patients included in this study. In addition to the standard diets, oral nutritional product (372 calories, 61 g protein, 30 g glutamine, and 30 g arginine/100 g powder sachet twice a day) gave to patients. Before the study and after three months from the supportive therapy; anthropometric measurements with serum urea, creatinine, total protein, albumin, cholesterol, KtV, body mass index was analyzed.

Results: The mean age of peritoneal dialysis patients was 60 (46-78) years. Serum urea levels from 96 ± 44 to 109 ± 42 mg/dL (p = 0.007), total protein levels from 5.85 ± 0.68 to 6.18 ± 0.66 g/dL (7.8%, p = 0.007), albumin levels increased from 3.02 ± 0.27 to 3.32 ± 0.34 g/dL (11.7%, p = 0.003) increased significantly after an average of 0.43 g/kg protein and 178 cal/day energy support.

Conclusions: Albumin is an indicator of malnutrition related mortality. Therefore, using of protein nutritional products in addition to standard treatment may be beneficial for malnourished peritoneal dialysis patients.

Keywords

References

  1. 1. Ma L, Zhao S. Risk factors for mortality in patients undergoing hemodialysis: a systematic review and metaanalysis. Int J Cardiol.2017;238:151-8.
  2. 2. Stenvinkel P, Heimbürger O, Lindholm B. Wasting, but not malnutrition, predicts cardiovascular mortality in end-stage renal disease. Nephrol Dial Transplant 2004;19:2181-3.
  3. 3. Kopple JD. National Kidney Foundation K/DOQI Work Group. The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients. Am J Kidney Dis 2001;38(4Suppl1):S68-73.
  4. 4. Uhlig K, Macleod A, Craig J, Lau J, Levey AS, Levin A, et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006;70:2058-65.
  5. 5. LeveyAS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-100.
  6. 6. Mak RH, CheungW. Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol 2006;21:1807-14.
  7. 7. LindholmB, Heimbürger O, Stenvinkel P. What are the causes of protein-energy PEW in chronic renal insufficiency? Am J Kidney Dis 2002;39:422-5.
  8. 8. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.

Details

Primary Language

English

Subjects

Urology

Journal Section

Research Article

Publication Date

March 4, 2021

Submission Date

January 9, 2020

Acceptance Date

December 8, 2020

Published in Issue

Year 2021 Volume: 7 Number: 2

AMA
1.Usta M, Ersoy A, Ayar Y. The effectiveness of oral protein supplementation in malnourished peritoneal dialysis patients. Eur Res J. 2021;7(2):192-195. doi:10.18621/eurj.672787